Operating Lease, Liability, Current in USD of Prelude Therapeutics Inc from Q1 2021 to Q3 2025

Taxonomy & unit
us-gaap: USD
Description
Present value of lessee's discounted obligation for lease payments from operating lease, classified as current.
Summary
Prelude Therapeutics Inc quarterly Operating Lease, Liability, Current history and growth rate from Q1 2021 to Q3 2025.
  • Prelude Therapeutics Inc Operating Lease, Liability, Current for the quarter ending September 30, 2025 was $2.73M, a 15.3% increase year-over-year.
Operating Lease, Liability, Current, Quarterly (USD)
Operating Lease, Liability, Current, YoY Quarterly Growth (%)

Prelude Therapeutics Inc Quarterly Operating Lease, Liability, Current (USD)

Period Value YoY Chg Change % Date Report Filed
Q3 2025 $2.73M +$362K +15.3% Sep 30, 2025 10-Q 2025-11-12
Q2 2025 $2.71M +$479K +21.5% Jun 30, 2025 10-Q 2025-08-14
Q1 2025 $2.6M +$412K +18.8% Mar 31, 2025 10-Q 2025-05-06
Q4 2024 $2.49M +$1.01M +68.3% Dec 31, 2024 10-Q 2025-11-12
Q3 2024 $2.37M +$1.89M +398% Sep 30, 2024 10-Q 2024-11-06
Q2 2024 $2.23M +$1.29M +138% Jun 30, 2024 10-Q 2024-08-12
Q1 2024 $2.19M +$798K +57.4% Mar 31, 2024 10-Q 2024-05-07
Q4 2023 $1.48M -$351K -19.2% Dec 31, 2023 10-K 2025-03-10
Q3 2023 $475K -$913K -65.8% Sep 30, 2023 10-Q 2023-11-01
Q2 2023 $938K -$884K -48.5% Jun 30, 2023 10-Q 2023-08-03
Q1 2023 $1.39M -$469K -25.2% Mar 31, 2023 10-Q 2023-05-08
Q4 2022 $1.83M +$92K +5.29% Dec 31, 2022 10-K 2024-02-15
Q3 2022 $1.39M -$448K -24.4% Sep 30, 2022 10-Q 2022-11-14
Q2 2022 $1.82M +$419K +29.9% Jun 30, 2022 10-Q 2022-08-09
Q1 2022 $1.86M +$456K +32.5% Mar 31, 2022 10-Q 2022-05-10
Q4 2021 $1.74M Dec 31, 2021 10-K 2023-03-15
Q3 2021 $1.84M Sep 30, 2021 10-Q 2021-11-12
Q2 2021 $1.4M Jun 30, 2021 10-Q 2021-08-12
Q1 2021 $1.4M Mar 31, 2021 10-Q 2021-05-11
* An asterisk sign (*) next to the value indicates that the value is likely invalid.